Skip to main content
. 2020 Oct 8;11(23):6925–6938. doi: 10.7150/jca.47631

Table 4.

Metabolic pathway enrichment analysis based on capecitabine-related-adverse-effect related metabolites

Pathway Source External_id P-value Matched metabolite
Conjugation of carboxylic acids Reactome R-HSA-159424 0.0007 Hippurate, Alpha-N-Phenylacetyl-L-glutamine,
Amino Acid conjugation Reactome R-HSA-156587 0.0007 Hippurate, Alpha-N-Phenylacetyl-L-glutamine,
Glucose Homeostasis Wikipathways WP661 0.0016 Methionine, Hippurate,
Trans-sulfuration pathway Wikipathways WP4253 0.0027 Methionine, Creatinine,
Vitamin B12 Metabolism Wikipathways WP1533 0.0077 Methionine, Creatinine,
Phenylalanine metabolism - Homo sapiens (human) KEGG path:hsa00360 0.0181 Hippurate, Alpha-N-Phenylacetyl-L-glutamine,
Arginine and proline metabolism - Homo sapiens (human) KEGG path:hsa00330 0.0211 Creatinine, 4-Acetamidobutanoic acid,
Tryptophan metabolism - Homo sapiens (human) KEGG path:hsa00380 0.0226 Indoleacetic acid, Indoxyl,
Amino Acid metabolism Wikipathways WP3925 0.0367 Methionine, Indoleacetic acid,
Phase II - Conjugation of compounds Reactome R-HSA-156580 0.0468 Hippurate, Alpha-N-Phenylacetyl-L-glutamine,

Metabolic pathway enrichment analysis was carried by an on-line tool (CPDB, http://cpdb.molgen.mpg.de/). The pathway databases for matching included REACTOME, KEGG, SMPDB, and Wikipathways. The minimum overlap with input list was set as 2 and the p-value cutoff was set as 0.05.